Last reviewed · How we verify

Ecklonia cava Phlorotannin — Competitive Intelligence Brief

Ecklonia cava Phlorotannin (Ecklonia cava Phlorotannin) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Phlorotannin. Area: Cardiovascular.

phase 2 Phlorotannin Cardiovascular Small molecule Live · refreshed every 30 min

Target snapshot

Ecklonia cava Phlorotannin (Ecklonia cava Phlorotannin) — Bota Bio Co., Ltd.. Ecklonia cava Phlorotannin has antioxidant and anti-inflammatory properties.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Ecklonia cava Phlorotannin TARGET Ecklonia cava Phlorotannin Bota Bio Co., Ltd. phase 2 Phlorotannin

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Phlorotannin class)

  1. Bota Bio Co., Ltd. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Ecklonia cava Phlorotannin — Competitive Intelligence Brief. https://druglandscape.com/ci/ecklonia-cava-phlorotannin. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: